Trials / Unknown
UnknownNCT04915053
Black Garlic Nutraceuticals and Blood Pressure Control
Black Garlic Nutraceuticals Supplementation for the Control of Blood Pressure in Hypertension. A Triple-blind Randomized Placebo Control Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Universitat de Lleida · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Black garlic contains a series of allyl-sulfur compounds with the ability to modulate nitric oxide synthetase, angiotensin-converting enzyme system, and endothelial activation, which together could help better control blood pressure. The main objective of this study is to evaluate the effect on blood pressure and endothelial health of a daily intake of a black garlic supplement named ABG (registered mark), which has a higher concentration of black garlic bioactive compounds, in people with moderate hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ABG+ Black Garlin | Daily tablet intake during three months |
| DIETARY_SUPPLEMENT | Crystalline Cellulose | Daily tablet intake during three months |
Timeline
- Start date
- 2021-05-15
- Primary completion
- 2021-12-31
- Completion
- 2022-06-30
- First posted
- 2021-06-07
- Last updated
- 2021-06-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04915053. Inclusion in this directory is not an endorsement.